Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 165

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Urinary Biomarkers and Renal Recovery in Critically Ill Patients with Renal Support

Open access
Srisawat, Nattachai, Wen, Xiaoyan, Lee, MinJae, Kong, Lan, Elder, Michele, Carter, Melinda, Unruh, Mark, Finkel, Kevin, Vijayan, Anitha, Ramkumar, Mohan, Paganini, Emil, Singbartl, Kai, Palevsky, Paul M., Kellum, John A.·2011·Clinical Journal of the American Society of Nephrology

Abstract

Summary: Background and objectives: Despite significant advances in the epidemiology of acute kidney injury (AKI), prognostication remains a major clinical challenge. Unfortunately, no reliable method to predict renal recovery exists. The discovery of biomarkers to aid in clinical risk prediction for recovery after AKI would represent a significant advance over current practice. Design, setting, participants, & measurements: We conducted the Biological Markers of Recovery for the Kidney study as an ancillary to the Acute Renal Failure Trial Network study. Urine samples were collected on days 1, 7, and 14 from 76 patients who developed AKI and received renal replacement therapy (RRT) in the intensive care unit. We explored whether levels of urinary neutrophil gelatinase-associated lipocalin (uNGAL), urinary hepatocyte growth factor (uHGF), urinary cystatin C (uCystatin C), IL-18, neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9, and urine creatinine could predict subsequent renal recovery. Results: We defined renal recovery as alive and free of dialysis at 60 days from the start of RRT. Patients who recovered had higher uCystatin C on day 1 (7.27 versus 6.60 ng/mg·creatinine) and lower uHGF on days 7 and 14 (2.97 versus 3.48 ng/mg·creatinine; 2.24 versus 3.40 ng/mg·creatinine). For predicting recovery, decreasing uNGAL and uHGF in the first 14 days was associated with greater odds of renal recovery. The most predictive model combined relative changes in biomarkers with clinical variables and resulted in an area under the receiver-operator characteristic curve of 0.94. Conclusions: We showed that a panel of urine biomarkers can augment clinical risk prediction for recovery after AKI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2215/cjn.11261210

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 165

Metadata

Authors
Srisawat, N., Wen, X., Lee, M., Kong, L., Elder, M., Carter, M., Unruh, M., Finkel, K., Vijayan, A., Ramkumar, M., Paganini, E., Singbartl, K., Palevsky, P. M., & Kellum, J. A.
Venue
Clinical Journal of the American Society of Nephrology
Published
2011-08
Volume
6
Issue
8
Pages
1815-1823
ISSN
1555-9041 (ISSN-L)
OpenAlex
W2139316042
Cited by
165
References
3
FWCI
9.21
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Urinary Biomarkers and Renal Recovery in Critically Ill Patients with Renal Support. https://app.cochat.ai/papers/10.2215/cjn.11261210
The paper
Srisawat, N., Wen, X., Lee, M., Kong, L., Elder, M., Carter, M., Unruh, M., Finkel, K., Vijayan, A., Ramkumar, M., Paganini, E., Singbartl, K., Palevsky, P. M., & Kellum, J. A. (2011). Urinary Biomarkers and Renal Recovery in Critically Ill Patients with Renal Support. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.11261210

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.